AI could revolutionize heart disease screening in poor regions

NCT ID NCT07599956

Not yet recruiting Diagnosis Sponsor: Children's Hospital Medical Center, Cincinnati Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether an AI tool called RADAR can help nurses in low-resource settings detect rheumatic heart disease more accurately using echocardiography. The goal is to make screening easier to scale up worldwide. The trial will enroll 62 nurse screeners at participating facilities.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI-assisted echocardiography (RADAR)
What this could lead to: If successful, this could make rheumatic heart disease screening faster and more accessible in low-resource areas, helping catch the disease earlier.
What could go wrong: This is a small, early-stage study (62 participants) focused on screening accuracy, not treatment. The AI may not perform as well in real-world settings or different populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATIC HEART DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

rheumatic heart disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RHEUMATIC HEART DISEASE

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Uganda Heart Institute

Kampala, Uganda

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.